InsidersTradesSigma
Track the Scholar Rock Holding Corp. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €6.9bn. The latest transaction was filed on 6 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Mohammed Qatanani. The full history is free.
Analysts rate Scholar Rock Holding Corp. Strong Buy (bullish), based on 16 analysts. Average price target: US$59.31.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Scholar Rock Holding Corp. is a biopharmaceutical company focused on developing targeted therapies for serious diseases. The company utilizes its drug discovery platform to identify innovative therapeutic candidates.